Trials / Conditions / Dyskinesia, Drug-Induced

Dyskinesia, Drug-Induced

10 registered clinical trials studyying Dyskinesia, Drug-Induced — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	rTMS as an Intervention for Levodopa-induced Dyskinesia NCT06570824	Danish Research Centre for Magnetic Resonance	N/A
Terminated	Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-bas NCT05116813	Addex Pharma S.A.	Phase 2 / Phase 3
Terminated	Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therap NCT04857359	Addex Pharma S.A.	Phase 2 / Phase 3
Withdrawn	Safinamide for Levodopa-induced Dyskinesia (PD-LID) NCT03987750	Zambon SpA	Phase 3
Completed	Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors NCT04064294	VA Office of Research and Development	—
Completed	Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease NCT03354455	Danish Research Centre for Magnetic Resonance	N/A
Completed	Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesia NCT01173731	Novartis Pharmaceuticals	Phase 2
Unknown	Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia NCT00837707	Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan	Phase 4
Terminated	Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizo NCT00686699	Merck Sharp & Dohme LLC	Phase 2
Completed	Movement Disorders Caused by Antipsychotic Drugs in Older Patients NCT00255879	University of California, San Diego	Phase 1